BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38058071)

  • 1. The Diagnostic Value of
    Cui B; Wu Z; Yu B; Li Y; Liu H
    Discov Med; 2023 Dec; 35(179):1064-1070. PubMed ID: 38058071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between BRAF
    Shangguan R; Hu YP; Huang J; Yang SJ; Ye L; Lin RX; Zhu J; Zhang TL; Ying L; Li P
    Acad Radiol; 2019 Feb; 26(2):154-160. PubMed ID: 29941398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
    Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of diagnostic value of SWE, FNA and BRAF gene detection in ACR TI-RADS 4 and 5 thyroid nodules.
    Zhang WB; Deng WF; Mao L; He BL; Liu H; Chen J; Liu Y; Qi TY
    Clin Hemorheol Microcirc; 2022; 81(1):13-21. PubMed ID: 35068450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
    Sheng D; Yu X; Li H; Zhang M; Chen J
    Medicine (Baltimore); 2021 Sep; 100(37):e27167. PubMed ID: 34664843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the diagnostic performance of contrast-enhanced ultrasound combined with
    Zhu X; Peng X; Zhu L; Xie L; Cheng F; Zhou B
    Gland Surg; 2021 Jan; 10(1):328-335. PubMed ID: 33633989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
    Moon HJ; Kim EK; Chung WY; Choi JR; Yoon JH; Kwak JY
    Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH; Kim BS; Kang KH; Kim HS
    World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
    Choi SH; Baek JH; Lee JH; Choi YJ; Song DE; Chung KW; Kim TY; Shong YK
    Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhu Y; Wu H; Huang B; Shen X; Cai G; Gu X
    Gland Surg; 2020 Oct; 9(5):1674-1684. PubMed ID: 33224845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
    Zhang YZ; Xu T; Cui D; Li X; Yao Q; Gong HY; Liu XY; Chen HH; Jiang L; Ye XH; Zhang ZH; Shen MP; Duan Y; Yang T; Wu XH
    Sci Rep; 2015 Nov; 5():16927. PubMed ID: 26597052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
    J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of DP-TOF Mass Spectroscopy (MS) and Next Generation Sequencing (NGS) methods for detecting molecular mutations in thyroid nodules fine needle aspiration biopsies.
    Qian XQ; Agyekum EA; Zhao LL; Yu RL; Li XY; Gu DJ; Yan N; Xu M; Yuan Y; Wang YG; Xin-Ping W; Xu FJ
    Front Endocrinol (Lausanne); 2022; 13():928788. PubMed ID: 35992139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.